| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |